查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2152445

腦脊髓液管理市場規模、佔有率和趨勢分析報告：按產品、閥門、類型、年齡、地區和細分市場預測（2026-2033 年）

Cerebral Spinal Fluid Management Market Size, Share & Trends Analysis Report By Product (CSF Shunts, By CSF Drainage), By Valve (Adjustable Valve Shunts), By Type, By Age, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計到 2025 年，全球腦脊髓液管理市場規模將達到 7.242 億美元，到 2026 年將成長至 7.619 億美元，到 2033 年將達到 11 億美元，2026 年至 2033 年的複合年成長率為 5.4%。

腦脊髓液（CSF）是存在於腦室中的血漿超過濾濾液，在輸送營養、清除代謝廢物和保護大腦方面發揮至關重要的作用。腦脊髓液在腦室中過度積聚會導致水腦症等疾病。推動市場成長的動力是全球對腦脊髓液管理的需求日益成長，以治療水腦症和其他腦部疾病。

市場成長的主要驅動力是水腦症和腦膜炎等神經系統疾病發生率的上升，這些疾病需要有效的腦脊髓液管理方案。此外，醫療技術的進步使得更有效率、更微創的治療方法得以開發，也顯著促進了市場成長。老年人口的不斷成長，以及老年人更容易患神經系統疾病，也進一步推動了市場需求。

此外，由於神經系統疾病的日益普遍，醫療設備產業正經歷著快速成長和創新。領先企業正在推出融合先進技術的新產品，預計這將對市場成長產生積極影響，使這一趨勢成為該行業的重要機會。

此外，由於開發中國家技術應用潛力巨大，腦脊髓液（CSF）管理市場預計將會擴張。這主要受腦脊髓液相關疾病盛行率上升、市場參與企業數量不斷增加以及對高效腦脊髓液管理解決方案的需求日益成長等因素驅動。此外，在政府對醫療技術的投資以及醫療設備產業蓬勃發展的推動下，新興經濟體的醫療保健產業正在快速發展。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：腦脊髓液管理市場：變數、趨勢與範圍

  • 市場概況及未來展望
  • 市場規模和成長前景
  • 市場動態
  • 腦脊髓液管理市場分析工具

第4章：腦脊髓液管理市場：產品特定估算與趨勢分析

  • 腦脊髓液管理市場：產品特定趨勢分析，2025 年和 2033 年
  • 腦脊髓液分流術
  • 腦脊髓液引流

第5章：腦脊髓液管理市場：依閥門類型分類的估價與趨勢分析

  • 腦脊髓液管理市場：閥門特定波動分析，2025 年和 2033 年
  • 可調式分流閥
  • 單壓閥分流

第6章：腦脊髓液管理市場：按類型分類的估算與趨勢分析

  • 腦脊髓液管理市場：按類型分類的趨勢分析，2025 年和 2033 年
  • 腦室腹腔分流術（VP分流術）
  • 心室-心房分流術（VA分流術）
  • 腰椎腹腔分流術（LP分流術）
  • 腦室胸膜分流術（VPL）

第7章 腦脊髓液管理市場：依年齡層別分類的估計與趨勢分析

  • 腦脊髓液管理市場：按年齡層別分類的趨勢分析，2025 年和 2033 年
  • 成人
  • 兒童

第8章：腦脊髓液管理市場：區域估算與趨勢分析

  • 2025 年及 2033 年各地區腦脊髓液管理市場展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 南非
    • 科威特

第9章 競爭情勢

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • B. Braun Melsungen AG
    • Integra LifeSciences Corporation
    • Spiegelberg GmbH & Co. KG
    • Medtronic
    • Sophysa
    • Beckersmith Medical, Inc
    • Natus Medical Inc.
    • Elekta AB
    • Phoenix Biomedical Corp.
簡介目錄
Product Code: GVR-1-68038-373-7

The global cerebral spinal fluid management market size was valued at USD 724.2 million in 2025 and is projected to grow from USD 761.9 million in 2026 to USD 1,100 million in 2033, at a CAGR of 5.4% from 2026 to 2033. Cerebrospinal fluid, an ultrafiltrate of plasma found in the brain's ventricles, plays crucial roles in supplying nutrients, removing waste, and protecting the brain. Accumulation of excessive cerebrospinal fluid in the brain's cavities can lead to conditions such as hydrocephalus. Market growth is driven by the rising need for cerebrospinal fluid (CSF) management to treat Hydrocephalus and other brain-related disorders worldwide.

Market growth is primarily driven by the rising incidence of neurological disorders, such as hydrocephalus and meningitis, which require effective cerebrospinal fluid (CSF) management solutions. In addition, advancements in medical technology have significantly contributed to this growth by enabling the development of more efficient, less invasive treatment methods. The rising geriatric population, which is more vulnerable to neurological conditions, further boosts market demand.

Moreover, the medical device sector is experiencing rapid growth and innovation due to the increasing prevalence of neurological diseases. This trend presents significant opportunities for the industry, as key players are introducing new products featuring advanced technology, which is expected to positively impact market growth.

The CSF management market is also anticipated to expand due to the high potential for technology adoption in developing countries. This is driven by the rising prevalence of CSF-related disorders, the increasing number of market participants, and the growing demand for effective CSF management solutions. Furthermore, the healthcare industry in emerging economies is rapidly developing, supported by government investments in medical technology and the establishment of robust medical device industries.

Global Cerebral Spinal Fluid Management Market Report Segmentation

This report forecasts revenue growth at product, age group, and country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the cerebral spinal fluid management market report based on product, valve, type, age group, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)

CSF Shunts

CSF Drainage

  • Valve Outlook (Revenue, USD Million, 2021 - 2033)

Adjustable Valve Shunts

Mono-pressure Valve Shunts

  • Type Outlook (Revenue, USD Million, 2021 - 2033)

Ventriculoperitoneal (VP) Shunts

Ventriculoatrial (VA) Shunts

Lumboperitoneal (LP) Shunts

Ventriculopleural (VPL) Shunts

  • Age Group Outlook (Revenue, USD Million, 2021 - 2033)

Adult

Pediatric

  • Regional Outlook (Revenue, USD Million, 2021 - 2033)

North America

    • U.S.
    • Canada
    • Mexico

Europe

    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Asia Pacific

    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand

Latin America

    • Brazil
    • Argentina

Middle East and Africa (MEA)

    • Saudi Arabia
    • UAE
    • South Africa
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Cerebral Spinal Fluid Management Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Cerebral Spinal Fluid Management Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Cerebral Spinal Fluid Management Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Cerebral Spinal Fluid Management Market: Product Movement Analysis, USD Million, 2025 & 2033
  • 4.3. CSF Shunts
    • 4.3.1. CSF Shunts Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. CSF Drainage
    • 4.4.1. CSF Drainage Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Cerebral Spinal Fluid Management Market: Valve Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Cerebral Spinal Fluid Management Market: Valve Movement Analysis, USD Million, 2025 & 2033
  • 5.3. Adjustable Valve Shunts
    • 5.3.1. Adjustable Valve Shunts Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Mono-pressure Valve Shunts
    • 5.4.1. Mono-pressure Valve Shunts Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Cerebral Spinal Fluid Management Market: Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Cerebral Spinal Fluid Management Market: Type Movement Analysis, USD Million, 2025 & 2033
  • 6.3. Ventriculoperitoneal (VP) Shunts
    • 6.3.1. Ventriculoperitoneal (VP) Shunts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Ventriculoatrial (VA) Shunts
    • 6.4.1. Ventriculoatrial (VA) Shunts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Lumboperitoneal (LP) Shunts
    • 6.5.1. Lumboperitoneal (LP) Shunts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Ventriculopleural (VPL) Shunts
    • 6.6.1. Ventriculopleural (VPL) Shunts Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Cerebral Spinal Fluid Management Market: Age Group Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Cerebral Spinal Fluid Management Market: Age Group Movement Analysis, USD Million, 2025 & 2033
  • 7.3. Adult
    • 7.3.1. Adult Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Pediatric
    • 7.4.1. Pediatric Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Cerebral Spinal Fluid Management Market: Regional Estimates & Trend Analysis

  • 8.1. Cerebral Spinal Fluid Management Market Share, By Region, 2025 & 2033, USD Million
  • 8.2. North America
    • 8.2.1. North America Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Japan Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Australia Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Saudi Arabia Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. UAE
      • 8.6.3.1. UAE Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. South Africa
      • 8.6.4.1. South Africa Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Cerebral Spinal Fluid Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. B. Braun Melsungen AG
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Integra LifeSciences Corporation
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Spiegelberg GmbH & Co. KG
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Medtronic
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Sophysa
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Beckersmith Medical, Inc
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Natus Medical Inc.
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Elekta AB
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. Phoenix Biomedical Corp.
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives